A Kv7.2 mutation associated with early onset epileptic encephalopathy with suppression-burst enhances Kv7/M channel activity

Epilepsia. 2016 May;57(5):e87-93. doi: 10.1111/epi.13366. Epub 2016 Mar 31.

Abstract

Mutations in the KCNQ2 gene encoding the voltage-gated potassium channel subunit Kv7.2 cause early onset epileptic encephalopathy (EOEE). Most mutations have been shown to induce a loss of function or to affect the subcellular distribution of Kv7 channels in neurons. Herein, we investigated functional consequences and subcellular distribution of the p.V175L mutation of Kv7.2 (Kv7.2(V175L) ) found in a patient presenting EOEE. We observed that the mutation produced a 25-40 mV hyperpolarizing shift of the conductance-voltage relationship of both the homomeric Kv7.2(V175L) and heteromeric Kv7.2(V175L) /Kv7.3 channels compared to wild-type channels and a 10 mV hyperpolarizing shift of Kv7.2(V175L) /Kv7.2/Kv7.3 channels in a 1:1:2 ratio mimicking the patient situation. Mutant channels also displayed faster activation kinetics and an increased current density that was prevented by 1 μm linopirdine. The p.V175L mutation did not affect the protein expression of Kv7 channels and its localization at the axon initial segment. We conclude that p.V175L is a gain of function mutation. This confirms previous observations showing that mutations having opposite consequences on M channels can produce EOEE. These findings alert us that drugs aiming to increase Kv7 channel activity might have adverse effects in EOEE in the case of gain-of-function variants.

Keywords: Axon initial segment; Early onset epileptic encephalopathy; Gain of function; KCNQ2; Linopirdine; M-current.

MeSH terms

  • Animals
  • Ankyrins / metabolism
  • Anticonvulsants / pharmacology
  • CHO Cells
  • Carbamates / pharmacology
  • Cricetulus
  • Electric Stimulation
  • Female
  • Hippocampus / cytology
  • Humans
  • Indoles / pharmacology
  • KCNQ2 Potassium Channel / genetics*
  • Male
  • Membrane Potentials / genetics
  • Membrane Potentials / physiology
  • Neurons / drug effects
  • Neurons / physiology
  • Patch-Clamp Techniques
  • Phenylenediamines / pharmacology
  • Polymorphism, Single Nucleotide / genetics*
  • Potassium Channel Blockers / pharmacology
  • Pyridines / pharmacology
  • Spasms, Infantile / genetics*

Substances

  • Ankyrins
  • Anticonvulsants
  • Carbamates
  • Indoles
  • KCNQ2 Potassium Channel
  • Phenylenediamines
  • Potassium Channel Blockers
  • Pyridines
  • ezogabine
  • linopirdine

Supplementary concepts

  • Infantile Epileptic-Dyskinetic Encephalopathy